• Working with

    passion, integrity,
    & true innovation

  • Developing

    novel, first-in-class therapeutics

  • Targeting

    major unmet medical needs

  • Changing

    the approach to
    treating cancer

Imetelstat

First-in-class, first-in-clinic,
telomerase inhibitor

 

Telomerase

Learn about our innovative approach to developing a treatment for cancer

 

Distribution of
Asterias Series A
Common Stock

Click here for important information

 

Geron News

8.11.2014

Geron Corporation Reports Second Quarter 2014 Financial Results

Read More

8.5.2014

Geron to Assume Sponsorship of Myelofibrosis IST and IND

Read More

7.30.2014

Geron Announces Conference Call to Discuss Second Quarter 2014 Financial Results

Read More

 

Events

8.11.2014

Geron Q2 2014 Conference Call

Listen to Webcast

6.4.2014

Geron at the Jefferies Healthcare Conference

Listen to Webcast

Download Slides

5.20.2014

Geron 2014 Annual Meeting of Stockholders

Learn more